The development of AL shows a long clinical latency with stepwise acquisition of oncogenic mutations, suggesting that Cdx2 expression predisposes cells to a pre-leukemic state with permissive conditions to the accumulation of cooperating secondary genetic events. The gene discussed is CDX2; the disease is axial length measurement.